Steven M. Friedman, EVP, Biology & Preclinical Development at INCYTE CORP (INCY), sold 22,000 shares at $10.90 ($240K) on 2010-01-08, disclosed to the SEC on 2010-01-08.
Open-market sale of $240k INCY by EVP, Biology & Preclinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.